berotek has been researched along with Pulmonary Hypertension in 2 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "If bronchospasmolytic agents are added, hypoxemia can be prohibited." | 1.26 | [The distribution of ventilation and perfusion in the obstructive syndrome during nitroglycerin and bronchospasmolytic therapy]. ( Borkenstein, J, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soon, E | 1 |
| Crosby, A | 1 |
| Southwood, M | 1 |
| Yang, P | 1 |
| Tajsic, T | 1 |
| Toshner, M | 1 |
| Appleby, S | 1 |
| Shanahan, CM | 1 |
| Bloch, KD | 1 |
| Pepke-Zaba, J | 1 |
| Upton, P | 1 |
| Morrell, NW | 1 |
| Borkenstein, J | 1 |
2 other studies available for berotek and Pulmonary Hypertension
| Article | Year |
|---|---|
Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Bone Morphogenetic Protein Receptors, Type II; Cyclic N-Oxides; Cytokines; Fe | 2015 |
[The distribution of ventilation and perfusion in the obstructive syndrome during nitroglycerin and bronchospasmolytic therapy].
Topics: Aged; Fenoterol; Humans; Hypertension, Pulmonary; Hypoxia; Lung; Lung Diseases, Obstructive; Male; M | 1979 |